CIPLA
Back to Cashflow Statement
|
CIPLA Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹3,940 Cr | ₹5,005 Cr | ₹4,134 Cr | ₹3,238 Cr | ₹3,326 Cr |
What is the latest Cash Flow from Operating Activities ratio of CIPLA ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹3,940 Cr |
| Mar2025 | ₹5,005 Cr |
| Mar2024 | ₹4,134 Cr |
| Mar2023 | ₹3,238 Cr |
| Mar2022 | ₹3,326 Cr |
How is Cash Flow from Operating Activities of CIPLA Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹3,940 Cr | -21.28 | |
| Mar2025 | ₹5,005 Cr | 21.07 | |
| Mar2024 | ₹4,134 Cr | 27.68 | |
| Mar2023 | ₹3,238 Cr | -2.65 | |
| Mar2022 | ₹3,326 Cr | - | |
Compare Cash Flow from Operating Activities of peers of CIPLA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CIPLA | ₹113,247.4 Cr | 1.6% | 4.4% | -9.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹437,963.0 Cr | 2.7% | 1.4% | 4.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹269,451.0 Cr | 4.5% | 6.3% | 50.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹179,456.0 Cr | 1.8% | -1.3% | 31.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹113,664.0 Cr | 0.8% | 12.5% | 14.1% | Stock Analytics | |
| MANKIND PHARMA | ₹103,881.0 Cr | 1.1% | 1.2% | 3.6% | Stock Analytics | |
CIPLA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CIPLA | 1.6% |
4.4% |
-9.1% |
| SENSEX | 7% |
9.6% |
-6.7% |
You may also like the below Video Courses